Matches in Wikidata for { <http://www.wikidata.org/entity/Q86170237> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- Q86170237 description "clinical trial" @default.
- Q86170237 description "ensayu clínicu" @default.
- Q86170237 description "klinisch onderzoek" @default.
- Q86170237 description "клінічне випробування" @default.
- Q86170237 description "կլինիկական փորձարկում" @default.
- Q86170237 name "Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections (2011-07-31)" @default.
- Q86170237 name "Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections (2011-07-31)" @default.
- Q86170237 type Item @default.
- Q86170237 label "Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections (2011-07-31)" @default.
- Q86170237 label "Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections (2011-07-31)" @default.
- Q86170237 prefLabel "Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections (2011-07-31)" @default.
- Q86170237 prefLabel "Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections (2011-07-31)" @default.
- Q86170237 P1050 Q86170237-1C25B10E-DEF6-4FFF-9960-13B946551E86 @default.
- Q86170237 P1050 Q86170237-B4989794-ABF3-4931-8577-68747C20E3B5 @default.
- Q86170237 P1132 Q86170237-C13981F8-DCF6-4A83-8070-D0B0DA1FD5F6 @default.
- Q86170237 P1476 Q86170237-473EBDBF-8A63-46B3-B650-AB9A16D9AA82 @default.
- Q86170237 P17 Q86170237-1027885E-0A3C-42BB-AD93-85306FB75F94 @default.
- Q86170237 P17 Q86170237-1A845409-D1E5-4C01-96C8-C7E781133915 @default.
- Q86170237 P17 Q86170237-492DAD5B-98DC-4C44-9161-266BC1CF8A57 @default.
- Q86170237 P17 Q86170237-5A8D8A1D-5745-4C8A-9783-1BA8E01EAA51 @default.
- Q86170237 P17 Q86170237-68A2E5E3-BCAC-44A6-A82A-26492618E245 @default.
- Q86170237 P17 Q86170237-9A4ED5F7-DBC0-4E6B-87DF-D65465255041 @default.
- Q86170237 P17 Q86170237-B19C4D17-AE9E-4A0E-8D8F-B6D39C4A374B @default.
- Q86170237 P17 Q86170237-C7078AFD-760A-4C62-85F2-84A13EE8BAAA @default.
- Q86170237 P17 Q86170237-DD12827B-553A-49D1-BF4E-E983E2513E0F @default.
- Q86170237 P17 Q86170237-DD249931-184C-40EE-B3C6-5F5E85EEB130 @default.
- Q86170237 P17 Q86170237-F2FD9E93-E3D1-4F9C-8EF2-D64B2AAA68CB @default.
- Q86170237 P17 Q86170237-FF862646-27E9-4052-B801-93F177617CE6 @default.
- Q86170237 P2899 Q86170237-E7625E43-8D3D-4DFE-9B36-FDDE7EA6A26E @default.
- Q86170237 P3098 Q86170237-F0BF7676-6EC4-4B15-8FA6-E3826476CF7C @default.
- Q86170237 P31 Q86170237-F153347D-AE5F-40FF-8F3E-78AD704AD540 @default.
- Q86170237 P4135 Q86170237-90E4455A-5FE5-48FA-8574-9436660733DE @default.
- Q86170237 P4844 Q86170237-5574BF28-F3D9-4269-9C8F-DE7B39FF5964 @default.
- Q86170237 P4844 Q86170237-5A5D922E-E4D3-4339-8262-ABAF11C5C3A7 @default.
- Q86170237 P4844 Q86170237-E6DDE49A-9E03-4CA7-8ABC-0AF1CA97EE55 @default.
- Q86170237 P4844 Q86170237-F625488D-9050-4962-B22F-1B4DA8197FC0 @default.
- Q86170237 P580 Q86170237-4A182CBF-680E-4260-9CF7-B94E33B1C369 @default.
- Q86170237 P582 Q86170237-1606DFF2-7A21-411A-AE8A-EFE85DE8BE7A @default.
- Q86170237 P6099 Q86170237-606B1272-02B3-4AE9-91ED-CF3D430911D4 @default.
- Q86170237 P8363 Q86170237-AD3E2E0B-8AB3-446D-BA3A-85DEF0C6BAFB @default.
- Q86170237 P1050 Q2112335 @default.
- Q86170237 P1050 Q876887 @default.
- Q86170237 P1132 "+739" @default.
- Q86170237 P1476 "A Phase 3, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Dalbavancin to a Comparator Regimen (Vancomycin and Linezolid) for the Treatment of Acute Bacterial Skin and Skin Structure Infections" @default.
- Q86170237 P17 Q191 @default.
- Q86170237 P17 Q211 @default.
- Q86170237 P17 Q212 @default.
- Q86170237 P17 Q214 @default.
- Q86170237 P17 Q218 @default.
- Q86170237 P17 Q219 @default.
- Q86170237 P17 Q258 @default.
- Q86170237 P17 Q28 @default.
- Q86170237 P17 Q30 @default.
- Q86170237 P17 Q37 @default.
- Q86170237 P17 Q801 @default.
- Q86170237 P17 Q865 @default.
- Q86170237 P2899 "+18" @default.
- Q86170237 P3098 "NCT01431339" @default.
- Q86170237 P31 Q30612 @default.
- Q86170237 P4135 "+85" @default.
- Q86170237 P4844 Q2731762 @default.
- Q86170237 P4844 Q411377 @default.
- Q86170237 P4844 Q424027 @default.
- Q86170237 P4844 Q5210237 @default.
- Q86170237 P580 "2011-07-01T00:00:00Z" @default.
- Q86170237 P582 "2012-11-01T00:00:00Z" @default.
- Q86170237 P6099 Q42824827 @default.
- Q86170237 P8363 Q78089383 @default.